Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Fascinating Fishing Objections From Around The World - 2More parents refusing this shot that prevents serious bleeding at birth
- 3Misremembering might actually be a sign your memory is working optimally
- 4Bother Control Administrations for 2024: Decide for Your Home
- 5Investigating the Medical advantages of Aloe Vera
- Figure out How to Alter Your Volvo XC40 for Further developed Solace
- Fundamental Monetary Guidance for Going into Business
- Paratroopers kill terrorist who threw rocks at Israeli citizens, soldiers near Ofra in West Bank
- Dominating the Art of Composing: Creator Bits of knowledge
- Famous Places to get-away for Americans
- Experience Unrivaled Sound: Top Speakers You Really want to Hear
- Language Learning Applications for Voyagers
- Investigation reveals sperm donor passed on cancer risk to dozens of children across Europe
- The most effective method to Amplify Profits from Gold Speculation: Systems and Tips
